Selective cyclooxygenase-2 inhibitors from Calophyllum membranaceum

被引:44
|
作者
Zou, J
Jin, DZ
Chen, WL
Wang, J
Liu, QF
Zhu, XZ [1 ]
Zhao, WM
机构
[1] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai Inst Biol Sci, Dept Pharmacol, Shanghai 201203, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai Inst Biol Sci, Dept Nat Prod, Shanghai 201203, Peoples R China
[3] Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China
来源
JOURNAL OF NATURAL PRODUCTS | 2005年 / 68卷 / 10期
关键词
D O I
10.1021/np0502342
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Chemical investigation of the anti-inflammatory Chinese folk medicine Calophyllum membranaceum has resulted in the isolation and characterization of three new xanthones (1-3), one new biphenyl C-glycoside (4), and one new phenylethanoid glycoside (5) along with 17 known compounds. Their structures were characterized on the basis of spectroscopic and chemical methods. Two xanthones, 2,6-dihydroxy-1,7-dimethoxyxanthone (1) and 3,4-dihydroxyxanthone, were found to exhibit selective inhibitory activity against cyclooxygenase-2 (IC50 = 2.99 and 1.80 mu M) in vitro.
引用
收藏
页码:1514 / 1518
页数:5
相关论文
共 50 条
  • [21] Selective cyclooxygenase-2 inhibitors: similarities and differences
    Brune, K
    Hinz, B
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2004, 33 (01) : 1 - 6
  • [22] Selective cyclooxygenase-2 inhibitors for the treatment of arthritis
    Fung, HB
    Kirschenbaum, HL
    CLINICAL THERAPEUTICS, 1999, 21 (07) : 1131 - 1157
  • [23] Cardiovascular risk of selective cyclooxygenase-2 inhibitors
    Schrör, K
    Mehta, P
    Mehta, JL
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2005, 10 (02) : 95 - 101
  • [24] Benzoylazulene derivatives as selective cyclooxygenase-2 inhibitors
    Takeuchi, S
    Yokota, M
    Kasai, R
    Ohkura, Y
    Tomiyama, T
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U253 - U253
  • [25] Pyridazinones as selective cyclooxygenase-2 inhibitors.
    Li, CS
    Brideau, C
    Chan, CC
    Savoie, C
    Claveau, D
    Charleson, S
    Gordon, R
    Greig, G
    Gauthier, JY
    Lau, CK
    Riendeau, D
    Therien, M
    Wong, E
    Prasit, P
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U210 - U210
  • [27] Selective cyclooxygenase-2 inhibitors development in cardiovascular medicine
    Praticò, D
    Dognè, JM
    CIRCULATION, 2005, 112 (07) : 1073 - 1079
  • [28] Selective inhibitors of cyclooxygenase-2 - Potential in elderly patients
    Davies, NMH
    Wallace, JL
    DRUGS & AGING, 1996, 9 (06) : 406 - 417
  • [29] Renal and cardiovascular effects of selective cyclooxygenase-2 inhibitors
    Komers, R
    Anderson, S
    Epstein, M
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (06) : 1145 - 1157
  • [30] Selective cyclooxygenase-2 inhibitors: Belief, hope, reality!
    Brune, K
    Hinz, B
    AKTUELLE RHEUMATOLOGIE, 1998, 23 (01) : 1 - 5